LYCOS RETRIEVER 
Chiron: Plants
built 211 days ago
Chiron acquired the owner of the Liverpool plant, PowderJect Pharmaceuticals, in July 2003 to expand its vaccine business. That merger was completed shortly after Mr. Pien took over, though the deal had been planned before he arrived. PowderJect, in turn, had acquired the factory in 2000 from Celltech, which owned it for about seven months.
Source:
Before the release of the earnings report, Chiron shares lost 73 cents, or 2.29 percent, to close at $31.13. In after-hours trading, the shares gained 32 cents, or 1.03 percent. The stock has dropped 31 percent since British regulators suspended the Liverpool plant's license Oct. 5.
Source:
The FDA is working to approve other flu-shot vaccine suppliers, but the Chiron plant is crucial. It was one of only two plants, along with one owned by Sanofi Pasteur, fully licensed last year to make flu-shot vaccine for U.S. consumers.
Source:
MORE ABOUT
Plants